After its founding in 1976, scientists at Genentech worked methodically toward the development of its first biotechnology product. It was nearly a decade later that the FDA approved Protropin, a ...

Generative artificial intelligence is moving from the margins of pharma into the center of how new medicines are imagined, ...

British Columbia's overdose-prevention safer supply program will require a witness when a user takes their drugs.

A model known as ConPLex can predict whether potential drug molecules will interact with specific protein targets, without having to perform the computationally intensive calculation of the molecules' ...

RNA plays a vital role in how our genes are expressed and how diseases develop. Yet, because RNA molecules constantly change shape, understanding how they work has long been a major scientific ...

A prestigious science award has been given to a man who created a new generative AI language model capable of identifying the exact chemical structure of designer drugs, even drugs that have not been ...

This article is the latest in the Health Affairs Forefront featured topic, Accountable Care for Population Health, featuring analysis and discussion of how to understand, design, support, and measure ...

Four drug manufacturers have announced plans to offer discounted drug prices to safety net providers under the federal 340B program via rebates instead of upfront discounts, despite the federal ...